Covered recipient · General Payments record
CAMILLE I FOLKARD
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$2,642.87
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $790.57 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $162.07 | 8 |
| BOSTON SCIENTIFIC CORPORATION | $123.11 | 1 |
| Amgen Inc. | $85.29 | 4 |
| ABBVIE INC. | $83.60 | 5 |
| PFIZER INC. | $70.57 | 4 |
| MannKind Corporation | $50.15 | 3 |
| DEXCOM, INC. | $46.06 | 2 |
| Alvogen Inc | $36.90 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.64 | 1 |
| Antares Pharma, Inc. | $25.22 | 1 |
| CHIESI USA, INC. | $24.46 | 1 |
| Lilly USA, LLC | $19.71 | 1 |
| Abbott Laboratories | $19.12 | 1 |
| Corcept Therapeutics | $18.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.12 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124996783 | CMS |
| ABBVIE INC. | $16.15 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103740355 | CMS |
| ABBVIE INC. | $19.23 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103740357 | CMS |
| ABBVIE INC. | $15.63 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103740359 | CMS |
| ABBVIE INC. | $15.08 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103740361 | CMS |
| ABBVIE INC. | $17.51 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103740363 | CMS |
| Alvogen Inc | $17.93 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137624229 | CMS |
| Alvogen Inc | $18.97 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137624234 | CMS |
| Amgen Inc. | $29.54 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111575968 | CMS |
| Amgen Inc. | $16.63 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111575970 | CMS |
| Amgen Inc. | $19.70 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111575972 | CMS |
| Amgen Inc. | $19.42 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111575974 | CMS |
| Antares Pharma, Inc. | $25.22 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146458530 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.64 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117970050 | CMS |
| Boston Scientific Corporation | $123.11 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092603368 | CMS |
| Chiesi USA, Inc. | $24.46 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151806280 | CMS |
| Corcept Therapeutics | $18.67 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117746719 | CMS |
| Dexcom, Inc. | $22.16 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289842 | CMS |
| Dexcom, Inc. | $23.90 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289846 | CMS |
| Lilly USA, LLC | $19.71 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136079413 | CMS |
| Mannkind Corporation | $16.69 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145842042 | CMS |
| Mannkind Corporation | $14.67 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145842044 | CMS |
| Mannkind Corporation | $18.79 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145842046 | CMS |
| Novo Nordisk Inc | $23.15 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096814408 | CMS |
| Novo Nordisk Inc | $16.84 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097713115 | CMS |
| Novo Nordisk Inc | $21.29 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097474976 | CMS |
| Novo Nordisk Inc | $14.97 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097274908 | CMS |
| Novo Nordisk Inc | $21.78 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096963632 | CMS |
| Novo Nordisk Inc | $20.20 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097319955 | CMS |
| Novo Nordisk Inc | $22.26 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097497418 | CMS |
| Novo Nordisk Inc | $21.58 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096903567 | CMS |
| PFIZER INC. | $16.38 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130977444 | CMS |
| PFIZER INC. | $16.60 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131212627 | CMS |
| PFIZER INC. | $18.33 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131425395 | CMS |
| PFIZER INC. | $19.26 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131867260 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.